Jump to content


Biomarker for Diffuse Scleroderma skin has been discovered!


Photo

EVOXAC Efficacy and Clinical Studies


  • Please log in to reply
1 reply to this topic

#1 janey

janey

    Platinum Member

  • ISN Support Specialists
  • PipPipPipPipPipPipPipPipPipPip
  • 2,118 posts
  • Location:New Mexico

Posted 03 May 2011 - 08:34 PM

EVOXAC Efficacy and Clinical Studies.

EVOXAC is a cholinergic agonist which binds to muscarinic receptors and significantly improves salivary flow for patients suffering from dry mouth associated with Sjögren's syndrome. Nine clinical trials have shown EVOXAC to be both safe and effective. Evoxac. April, 2011. (Also see: Sjogrens)

This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
Janey Willis
ISN Support Specialist
(Retired) ISN Assistant Webmaster
(Retired) ISN News Director
(Retired) ISN Technical Writer for Training Manuals
International Scleroderma Network (ISN)

#2 Indy

Indy

    Newbie

  • Members
  • Pip
  • 8 posts

Posted 04 May 2011 - 07:07 AM

I've been on this drug before. It does increase saliva flow; however, the down side is they are expensive pills and you have to take 2 or 3 per day. I found that if I took more than 1 per day, I would get sick to my stomach. They also make you sweat profusely after taking the pill for about the first couple of hours after taking. But again, they did help increase saliva production.